• Home
  • Doctor's Profile
Images
Total Views - 284

Dr Gaurav Dixit

  • My Availability Times
  • Monday : 10:00 AM - 00:00 AM & 00:00 AM - 06:00 AM
  • Tuesday : 10:00 AM - 00:00 AM & 00:00 AM - 06:00 PM
  • Wednesday : 10:00 AM - 00:00 AM & 00:00 AM - 06:00 PM
  • Thursday : 10:00 AM - 00:00 AM & 00:00 AM - 06:00 PM
  • Friday : 10:00 AM - 00:00 AM & 00:00 AM - 06:00 PM
  • Saturday : 10:00 AM - 00:00 AM & 00:00 AM - 06:00 PM

More Information

  • UNIT HEAD - HAEMATO ONCOLOGY at Artemis Hospitals
  • EXPERTISE: BMT,Haematopoietic Stem Cell Transplant,Hematology
  • QUALIFICATION: MBBS, MD- General Medicine, DM-Clinical Hematology
  • PRACTICING AT: Artemis Hospitals
  • TRAINED AT: AIIMS Delhi
  • ORGAN SPECIALIZATION:
    Bone Marrow Transplant(BMT)
    Paediatric and Adult Leukaemia
    Lymphoma
    Multiple Myeloma
    Aplastic Anemia
  • PUBLICATIONS: Ghalaut PS, Chaudhary U, Ghalaut VS, Aggarwal S, Sood V, Dixit G. Cefipime vs Ceftazidime as empirical therapy for fever in neutropenic patients with hematological malignancies. Indian j hematol blood transfusion 2007; 23 (3-4): 104 -106 Ghalaut PS, Sen R, Dixit G. Role of GCSF in chemotherapy induced neutropenia. JAPI 2008;56:942-944 Ghalaut PS, Chaudhary U, Ghalaut VS, Dhingra A, Dixit G, Aggarwal S. piperacillin Tazobactum plus amikacin vs Ceftazidime plus amikacin as empirical therapy for fever in neutropenic patients with hematological malignancies. Indian j hematol blood transfusion 2011; 27 (3): 131 -135 Dixit G, Dhingra A, Diksha K. Vincristine induced cranial neuropathy. JAPI 2012;60:56-58 Singh AK, Dixit G, Sharma S, Yadav R, Agrawal N, Sarkar C et al. Skin manifestations associated with mantle cell lymphoma : a case report. Mediter jour of hematol and infectious diseases 2013 ; 5(1) Oral presentation at Hematocon 2013 - incidence of invasive fungal infections following allogenic stem cell transplant - a single centre experience Oral presentation - APBMT 2015, Okinawa Japan , Iron chelation in ex thalassemics Naithani R, Dayal N, Dixit G. Single versus dual platform analysis for hematopoietic stem cell enumeration using ISHAGE protocol. Indian J Hematol Blood Transfus.2016
  • REGISTRATION: 41262
  • EDUCATION: MBBS, MD- General Medicine, DM-Clinical Hematology
  • ANY SUCCESS STORY:
    American Style of transplant and cellular therapy
    Asia Pacific Bone Marrow Transplant
    Indian Society of Haematology & Blood Transfusion
    Indian Medical Association
    Honors & Awards
    Professional certification in Multiple Myeloma - Mayo Clinic, January 2022



  • DESCRIPTION:
    Dr. Gaurav Dixit completed his MBBS and MD in General medicine from PGIMS Rohtak in 2008. After completing his senior residency in General Medicine, he joined the department of Clinical Hematology at AIIMS Delhi in 2011, and from there, he picked up an interest in the study and treatment of blood disorders. In 2012, he joined CMC Vellore, which has one of the best hematology departments in the country, for his DM degree.

    He worked for three years in this busy transplant center, before finishing in 2015. He joins Artemis Hospital after working for 4 years each in Max Hospital, Shalimar Bagh and Action Cancer Hospital. He was instrumental in setting up a bone marrow transplant program in both centers.
    In 2020, he was awarded the professional certificate in multiple myeloma by Mayo Clinic, U.S.A

    He possesses great clinical acumen and scientific insight. He is well-versed with the latest developments in the field of hematology and always follows set international guidelines for treating his patients. Due to his exceptional understanding of Hemato-Oncology, he holds a special place in the field.

    His teaching skills have been an asset to the department, wherever he has served. His special interests are leukemia, myeloma, lymphoma, and aplastic anemia. As a member of various organizations, in India and abroad, Dr. Gaurav is always willing to interact, learn and help. He has performed First Bone Marrow Transplant in Kenya in Oct 2022, successfully.

Images

Copyright © 2022-24 Health29. All Rights Reserved. Design & Developed By : Innovative Solution Technologies |  ISOLS Group